Yes, WES plays a crucial role in the development of personalized cancer treatments, also known as precision oncology. By identifying specific mutations in a patient's tumor, WES can help oncologists tailor treatments that target those mutations. For example, if WES reveals a mutation in the EGFR gene, a known driver of lung cancer, targeted therapies such as tyrosine kinase inhibitors can be prescribed to block the activity of the mutated protein.
